LINCOLN.NS

Lincoln Pharmaceuticals Limited
NSEINREQUITY Healthcare DELAYED
Last price
614.05
▼ 8.55 (1.37%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
629.00
Prev close
622.60
Day high
629.00
Day low
610.00
Volume
24.03K
Market cap
$12.30B
P/E (TTM)
12.76
52W range
440.00 – 770.00

Day trading desk

Current session · delayed
Gap from prior close
+1.03%
Prior close 622.60
VWAP
615.69
-0.27% from price
Relative volume
0.32×
Quiet session
Session range
3.11%
610.00 – 629.00
Position in range
21%
Near session low
ATR (14D)
23.24
3.78% of price
Prior day high
625.00
PDH
Prior day low
612.55
PDL
Bid / ask spread
Quote not published
Session volume
24.55K
Avg 76.04K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+0.11% +1.5%
1M
+4.55% +0.8%
3M
-17.85% -20.9%
6M
-3.24% -14.3%
YTD
+26.88% +14.6%
1Y
+13.16% -6.8%
3Y
+40.34% -33.8%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on LINCOLN.NS open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
11.24M
Total on file

Fundamentals

TTM · reported
Market cap$12.30B
Enterprise value$9.93B
Revenue (TTM)$6.94B
Gross profit$3.67B
EBITDA$1.01B
Net income$964.53M
EPS (TTM)$48.14
Free cash flow
Total cash$2.41B
Total debt$44.22M
Book value / share$378.34
Shares outstanding20.03M
Float9.26M
Short % of float
Dividend yield0.29%
Beta (5Y)0.39

Valuation & profitability ratios

Account required
Trailing P/E12.76
Forward P/E
PEG ratio
Price / sales
Price / book1.62
EV / revenue1.43
EV / EBITDA9.80
Gross margin52.91%
Operating margin13.28%
Profit margin13.89%
Return on equity
Return on assets
Debt / equity0.58
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 5 quarters
Blank means not reported, not zero
Line item20262025202420232022YoY
Total revenue $6.71B$6.23B$5.81B$5.05B +7.7%
Operating revenue $6.71B$6.23B$5.81B$5.05B +7.7%
Cost of revenue $3.11B$2.91B$2.80B$2.43B +6.8%
Gross profit $3.60B$3.32B$3.02B$2.62B +8.4%
Selling, general & admin $412.53M$379.50M$354.44M
Total operating expense $2.77B$2.43B$2.02B$1.81B +13.7%
Operating income $831.84M$885.94M$896.22M$806.75M -6.1%
Net interest income -$10.13M-$18.83M$55.58M$41.41M +46.2%
Pre-tax income $1.16B$1.09B$1.22B$1.00B +5.9%
Tax provision $277.31M$268.42M$289.38M$275.81M +3.3%
Net income $878.94M$823.46M$933.05M$728.99M +6.7%
Net income to common $878.94M$823.46M$933.05M$728.99M +6.7%
Basic EPS 43.8841.1146.5836.40 +6.7%
Diluted EPS 43.8841.1146.5836.40 +6.7%
EBIT $1.17B$1.11B$1.24B$1.02B +5.0%
EBITDA $1.31B$1.24B$1.34B$1.11B +5.8%
Basic shares 20.03M20.03M20.03M20.03M -0.0%
Diluted shares 20.03M20.03M20.03M20.03M -0.0%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Sep 2020 9.5110.46 +10.0%
Jun 2020 5.207.63 +46.7%
Mar 2020 6.104.47 -26.7%
Dec 2019 7.055.46 -22.5%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders56.12%
Held by institutions1.08%
Institutions holding10
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
610.54
+0.57% from price
SMA 20
599.45
+2.44% from price
SMA 50
607.40
+1.10% from price
SMA 100
624.05
-1.60% from price
SMA 200
576.60
+6.49% from price
EMA 12
609.93
+0.68% from price
EMA 26
605.99
+1.33% from price
EMA 50
609.36
+0.77% from price
RSI (14)
53.7
Neutral
MACD (12,26,9)
3.94
Hist 3.26
ATR (14)
23.24
3.78% of price
Realised vol 30D
24.7%
Annualised
Bollinger upper
632.04
20, 2σ
Bollinger lower
566.85
20, 2σ
50 / 200 cross
Golden
607.40 vs 576.60
Trend bias
Above 200
+6.49%

Options chain

Account required
ExpirySpot 614.05
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.23
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
24.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.5%
Peak to trough
Max drawdown 5Y
-53.4%
Peak to trough
ATR 14
23.24
3.78% of price
Beta (reported)
0.39
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$1.80 / yr
Forward yield0.29%
5-year avg yield
Payout ratio3.74%
Ex-dividend dateSep 12, 2025
Next pay date
Last split1:5
Split dateMar 19, 2009

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.